EA200970224A1 - Лечение заболеваний хряща - Google Patents
Лечение заболеваний хрящаInfo
- Publication number
- EA200970224A1 EA200970224A1 EA200970224A EA200970224A EA200970224A1 EA 200970224 A1 EA200970224 A1 EA 200970224A1 EA 200970224 A EA200970224 A EA 200970224A EA 200970224 A EA200970224 A EA 200970224A EA 200970224 A1 EA200970224 A1 EA 200970224A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- osteoarthritis
- brain diseases
- fgf
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Настоящее изобретение относится к лечению заболевания хряща и, в частности, остеоартрита. Более конкретно, оно относится к применению FGF-18 в схемах лечения и для изготовления лекарственного средства для лечения пациентов, имеющих заболевание хряща, такое как остеоартрит, такое как, например, остеоартрит коленного сустава или вторичный остеоартрит бедренного сустава. Особо представлена предпочтительная схема лечения, включающая введение один раз в неделю соединения FGF-18 за цикл лечения.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06119557 | 2006-08-25 | ||
US84060006P | 2006-08-28 | 2006-08-28 | |
PCT/EP2007/058830 WO2008023063A2 (en) | 2006-08-25 | 2007-08-24 | Treatment of cartilage disorders with fgf-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200970224A1 true EA200970224A1 (ru) | 2009-08-28 |
EA015644B1 EA015644B1 (ru) | 2011-10-31 |
Family
ID=38984134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200970224A EA015644B1 (ru) | 2006-08-25 | 2007-08-24 | Способ лечения заболеваний хряща |
Country Status (14)
Country | Link |
---|---|
US (1) | US8207115B2 (ru) |
EP (1) | EP2054050B1 (ru) |
JP (2) | JP5815206B2 (ru) |
KR (1) | KR101419961B1 (ru) |
AR (1) | AR062522A1 (ru) |
AU (1) | AU2007287510B2 (ru) |
CA (1) | CA2658511C (ru) |
CY (1) | CY1113136T1 (ru) |
EA (1) | EA015644B1 (ru) |
HR (1) | HRP20120643T1 (ru) |
IL (1) | IL197169A (ru) |
MX (1) | MX2009002063A (ru) |
PL (1) | PL2054050T3 (ru) |
WO (1) | WO2008023063A2 (ru) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012038953A2 (en) | 2010-09-21 | 2012-03-29 | Hepacore Ltd. | Fgf-18 truncated variants having increased receptor specificity and uses thereof |
WO2012140650A2 (en) | 2011-04-12 | 2012-10-18 | Hepacore Ltd. | Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof |
TWI527590B (zh) | 2011-06-17 | 2016-04-01 | 艾瑞斯貿易公司 | Fgf-18之凍乾調配物 |
CN104619727B (zh) | 2012-06-25 | 2019-04-05 | 布里格姆及妇女医院股份有限公司 | 靶向治疗 |
US9790264B2 (en) | 2012-06-25 | 2017-10-17 | The Brigham And Women's Hospital, Inc. | Compounds and methods for modulating pharmacokinetics |
CN104736723B (zh) * | 2012-08-06 | 2017-10-31 | 默克专利有限公司 | 用于预测对fgf‑18化合物的响应性的遗传标记 |
EP2880181B1 (en) * | 2012-08-06 | 2018-09-19 | Merck Patent GmbH | Prognosis biomarkers in cartilage disorders |
ES2865723T3 (es) | 2013-12-24 | 2021-10-15 | Ares Trading Sa | Formulación de FGF-18 en geles de xiloglucano |
CN106232153B (zh) * | 2014-02-20 | 2020-01-17 | 默克专利有限公司 | 用于移植和组织工程手术的fgf-18 |
SG11201606505UA (en) | 2014-02-20 | 2016-09-29 | Merck Patent Gmbh | Fgf-18 compound dosing regimen |
CA2971315C (en) | 2015-01-29 | 2023-02-14 | Ares Trading S.A. | Immunoassays for high positively charged proteins |
ES2927067T3 (es) * | 2015-03-03 | 2022-11-02 | Radius Health Inc | Abaloparatida combinada con alendronato para la reducción de las fracturas óseas no vertebrales |
EP4039253A1 (en) | 2015-04-29 | 2022-08-10 | Radius Pharmaceuticals, Inc. | Methods of treating cancer |
JP6951318B2 (ja) * | 2015-07-15 | 2021-10-20 | プロージット ソウル バイオテクノロジー (ベイジン) カンパニー リミテッド | 融合ポリペプチドおよび使用方法 |
EP3334450A1 (en) * | 2015-08-13 | 2018-06-20 | Merck Patent GmbH | Combination composition comprising fgf-18 compound |
EP3318563A1 (en) | 2016-11-07 | 2018-05-09 | Sanofi | Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders |
EP3565542B1 (en) | 2017-01-05 | 2024-04-10 | Radius Pharmaceuticals, Inc. | Polymorphic forms of rad1901-2hcl |
CN107338218B (zh) * | 2017-07-28 | 2020-11-24 | 中国人民解放军总医院第一附属医院 | 一种诱导脂肪干细胞向软骨细胞分化的诱导分化培养基和方法 |
RU2020113713A (ru) * | 2017-09-21 | 2021-10-21 | Мерк Патент Гмбх | Слитый белок, содержащий молекулу fgf-18 |
JP2020535436A (ja) * | 2017-09-29 | 2020-12-03 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | Fgf−18化合物に対する反応性を予測する代謝バイオマーカー |
CA3075713A1 (en) | 2017-09-29 | 2019-04-04 | Merck Patent Gmbh | Inflammatory biomarkers for predicting responsiveness to fgf-18 compound |
AU2019297421A1 (en) | 2018-07-04 | 2021-01-28 | Radius Pharmaceuticals, Inc. | Polymorphic forms of RAD 1901-2HCL |
SG11202102160VA (en) | 2018-09-10 | 2021-04-29 | Merck Patent Gmbh | Markers useful in enrichment strategies for the treatment of osteoarthritis |
WO2020104833A1 (en) * | 2018-11-19 | 2020-05-28 | 4P-Pharma | Composition and methods for regulating chondrocyte proliferation and increasing of cartilage matrix production |
WO2020161341A1 (en) | 2019-02-08 | 2020-08-13 | Merck Patent Gmbh | Treatment of patients at risk of rapid progression of osteoarthritis |
CN109836487B (zh) * | 2019-03-01 | 2022-06-17 | 重庆派金生物科技有限公司 | 一种人成纤维细胞生长因子18及其可溶性重组表达方法、制备方法、制剂和应用 |
CN117721115A (zh) * | 2022-09-06 | 2024-03-19 | 深圳瑞吉生物科技有限公司 | 用于治疗骨关节炎的mRNA及其制备方法与应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE269102T1 (de) | 1994-03-08 | 2004-07-15 | Osteosa Inc | Verwendung von fibroblastwachstumsfaktoren zur stimulierung des knochenwachstums |
US20050043234A1 (en) | 1996-10-16 | 2005-02-24 | Deisher Theresa A. | Novel FGF homologs |
JPH11332570A (ja) * | 1998-05-27 | 1999-12-07 | Shionogi & Co Ltd | 新規な線維芽細胞成長因子及びそれをコードする遺伝子 |
AU1804201A (en) * | 1999-12-02 | 2001-06-12 | Zymogenetics Inc. | Methods for targeting cells that express fibroblast growth receptor-3 or-2 |
KR20040055733A (ko) | 2001-02-28 | 2004-06-26 | 콘드로진 인코포레이티드 | 골관절염에 관련된 조성물 및 방법 |
AU2003279835B2 (en) * | 2002-10-07 | 2009-09-10 | Zymogenetics, Inc. | Methods of administering FGF18 |
CA2592044A1 (en) * | 2004-07-06 | 2006-02-09 | Zymogenetics, Inc. | Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use |
DK1828239T3 (da) * | 2004-12-10 | 2011-12-19 | Zymogenetics Inc | FGF18-produktion i prokaryote værter |
-
2007
- 2007-08-24 AR ARP070103770A patent/AR062522A1/es not_active Application Discontinuation
- 2007-08-24 AU AU2007287510A patent/AU2007287510B2/en active Active
- 2007-08-24 WO PCT/EP2007/058830 patent/WO2008023063A2/en active Application Filing
- 2007-08-24 EA EA200970224A patent/EA015644B1/ru unknown
- 2007-08-24 CA CA2658511A patent/CA2658511C/en active Active
- 2007-08-24 KR KR1020097006119A patent/KR101419961B1/ko active IP Right Grant
- 2007-08-24 US US12/374,488 patent/US8207115B2/en active Active
- 2007-08-24 PL PL07802876T patent/PL2054050T3/pl unknown
- 2007-08-24 EP EP07802876A patent/EP2054050B1/en active Active
- 2007-08-24 MX MX2009002063A patent/MX2009002063A/es active IP Right Grant
- 2007-08-24 JP JP2009525079A patent/JP5815206B2/ja active Active
-
2009
- 2009-02-22 IL IL197169A patent/IL197169A/en active IP Right Grant
-
2012
- 2012-08-08 HR HRP20120643TT patent/HRP20120643T1/hr unknown
- 2012-09-13 CY CY20121100837T patent/CY1113136T1/el unknown
-
2014
- 2014-01-14 JP JP2014004339A patent/JP2014088429A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2007287510A1 (en) | 2008-02-28 |
US20100016223A1 (en) | 2010-01-21 |
EA015644B1 (ru) | 2011-10-31 |
JP2014088429A (ja) | 2014-05-15 |
CA2658511A1 (en) | 2008-02-28 |
JP2010501531A (ja) | 2010-01-21 |
IL197169A (en) | 2013-08-29 |
WO2008023063A2 (en) | 2008-02-28 |
IL197169A0 (en) | 2009-12-24 |
JP5815206B2 (ja) | 2015-11-17 |
KR101419961B1 (ko) | 2014-07-30 |
WO2008023063A3 (en) | 2008-05-02 |
HRP20120643T1 (hr) | 2012-08-31 |
EP2054050A2 (en) | 2009-05-06 |
EP2054050B1 (en) | 2012-08-08 |
AU2007287510B2 (en) | 2012-08-30 |
CA2658511C (en) | 2019-02-19 |
PL2054050T3 (pl) | 2013-01-31 |
KR20090051100A (ko) | 2009-05-20 |
MX2009002063A (es) | 2009-03-06 |
US8207115B2 (en) | 2012-06-26 |
AR062522A1 (es) | 2008-11-12 |
CY1113136T1 (el) | 2016-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200970224A1 (ru) | Лечение заболеваний хряща | |
EA201791669A3 (ru) | Новые терапевтические подходы в лечении смт и связанных с ней расстройств | |
EA201270144A1 (ru) | Комбинированная терапия при лечении диабета | |
EA201290078A1 (ru) | Гетероциклические соединения для ингибирования pask | |
EA201100873A1 (ru) | Пиридилоксииндолы - ингибиторы vegf-r2 и их применение для лечения заболевания | |
NO20064186L (no) | Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod | |
ATE369353T1 (de) | Medizinisch verwendbare arylethanolamin verbindungen | |
EA201190217A1 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
EA200802204A1 (ru) | Применение ингибиторов dpp iv | |
EA201070046A1 (ru) | Способ получения лекарственного средства, содержащего тадалафил | |
EA200602016A1 (ru) | ПОРОШКОВЫЕ КОМПОЗИЦИИ ДЛЯ ИНГАЛЯЦИИ, СОДЕРЖАЩИЕ ЭНАНТИОМЕРНОЧИСТЫЕ β-АГОНИСТЫ | |
EA201071038A1 (ru) | Производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40 | |
EA200870254A1 (ru) | Способ лечения воспалительных заболеваний | |
EA200601846A1 (ru) | Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей | |
EA200971107A1 (ru) | Катехоламиновые производные, полезные для лечения болезни паркинсона | |
GB0620385D0 (en) | Novel compounds | |
UA99818C2 (ru) | Лечение заболеваний хряща | |
EA200801580A1 (ru) | Новые производные пирониндола и способ их получения | |
ATE485037T1 (de) | Krebsbehandlung mittels fts und 2-deoxyglucose | |
EA201071043A1 (ru) | Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1 и cx3cr1 | |
EA200701615A1 (ru) | Новые лекарственные средства для лечения заболеваний дыхательных путей | |
EA201170484A1 (ru) | Терапевтический режим лечения гепатита, включающий пэг-интерферон, рибавирин и vx-950 | |
MX2012001529A (es) | Derivados de 3-heteroaril-metil-imidazo-[1,2-b]-piridazin-6-ilo como moduladores de cinasa de tirosina c-met. | |
EA201171228A1 (ru) | Производные хиназолиндиона, их получение и их различные терапевтические применения | |
EA200970127A1 (ru) | Модулятор рецепторов глюкокортикостероидов и способы его применения |